Mandate

Vinge advises Coromatic Group in its acquisition of TN Service AB

February 10, 2009

Vinge has advised the Norwegian IT security group, Coromatic Group in connection with its acquisition of TN Service AB (TNS). As a result, Coromatic Group has become the Nordic region’s largest data halls service organisation.

TNS was founded in 1995 and currently specialises in the design, construction, service and maintenance of computers and IT environments. The company has 18 employees and approximately 300 service agreements. The acquisition of TNS is of significant strategic value for Coromatic AB since such complements the current organisation through technical and customer relationship synergies.  

Coromatic Group is a leading participant within physical IT security on the Nordic market. The group delivers complete data hall solutions as well as products and services within the non-interruption power supply field. The group was formed at the turn of the year 2007/2008 when Litorina Kapital became the majority shareholder of Coromatic AB, the Danish Scanpocon A/S, the Norwegian Metric AS and the Swedish Metric Power Systems AB. The group has a turnover in excess of half a billion and as a result of this acquisition has grown from 164 to 182 employees. The two companies have a combined customer base of over 800 service agreements.

Vinge’s team consisted of responsible partner Johan Winnerblad and associates Joacim Rydergård and Sara Hamilton.

Related

Vinge advised Precise Biometrics

Vinge has advised Precise Biometrics AB in connection with the merger with Fingerprint Cards.
March 27, 2026

Vinge has advised Xspray Pharma in connection with its rights issue

Vinge has advised Xspray Pharma AB (publ) in connection with a rights issue of approximately SEK 83 million before transaction costs, with an over-allotment issue of approximately SEK 30 million.
March 26, 2026

Vinge advises Diamyd Medical in connection with directed issuances of shares and warrants of up to SEK 1,166 million

Vinge advises Diamyd Medical Aktiebolag (“Diamyd Medical”), listed on Nasdaq First North Growth Market, in connection with directed issuances of shares and warrants whereby Diamyd Medical receives gross proceeds of approximately SEK 1,166 million, if all warrants are exercised.
March 25, 2026